Evidence map›Paper›PMID 39444915›Full record

ArticleJournal of thoracic disease2024

Early thoracic surgery consultation and location of therapy impact time to esophagectomy.

Ashley L Deeb, Aaron R Dezube, Antonio Lozano, Anupama Singh, Luis E De Leon, Suden Kucukak, Michael T Jaklitsch, Jon O Wee

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ashley L DeebDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Aaron R DezubeDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Antonio LozanoBoston University School of Medicine, Boston, MA, USA.
Anupama SinghDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Luis E De LeonDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Suden KucukakDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Michael T JaklitschDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Jon O WeeDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Neoadjuvant chemoradiation therapy (nCRT) followed by esophagectomy is the standard treatment for resectable, locally advanced esophageal cancer. The ideal timing between neoadjuvant therapy and esophagectomy is unclear. Delayed esophagectomy is associated with worse outcomes. We investigated which factors impacted time to esophagectomy in our patients. Methods: We conducted a retrospective analysis of prospectively collected data of patients with pT0-3N0-2 esophageal cancers who underwent CROSS trimodality therapy from May 2016 to January 2020. Sociodemographic factors, comorbidities, and neoadjuvant factors (location of CRT, treatment toxicity, discontinuation of treatment) were compared between patients who underwent surgery within 60 days and those after 60 days. Results: In total, 197 patients were analyzed of whom 137 underwent esophagectomy within 60 days (early surgery, ES) and 60 were outside that window (delayed surgery, DS). More DS patients had a history of myocardial infarction (MI) or stroke (both 11.67% Conclusions: Improving access to multispecialty cancer centers and increasing satellite sites may improve time to esophagectomy.

Indexed as

CROSS trimodality therapydelayed esophagectomyesophageal cancer

Identifiers

PMID39444915
PMCPMC11494582

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.